ATE482707T1 - 1-ä2h-1-benzopyran-2-on-8-ylü- piperazin- derivate zur behandlung von schmerzen - Google Patents

1-ä2h-1-benzopyran-2-on-8-ylü- piperazin- derivate zur behandlung von schmerzen

Info

Publication number
ATE482707T1
ATE482707T1 AT05729786T AT05729786T ATE482707T1 AT E482707 T1 ATE482707 T1 AT E482707T1 AT 05729786 T AT05729786 T AT 05729786T AT 05729786 T AT05729786 T AT 05729786T AT E482707 T1 ATE482707 T1 AT E482707T1
Authority
AT
Austria
Prior art keywords
ylü
benzopyran
pain
treatment
piperazine derivatives
Prior art date
Application number
AT05729786T
Other languages
English (en)
Inventor
Cornelis Bakker
Jeffrey Glennon
Mayke B Hesselink
Claudia Thaete
Andrew Mccreary
Scharrenburg Gustaaf J M Van
Original Assignee
Abbott Healthcare Products Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Healthcare Products Bv filed Critical Abbott Healthcare Products Bv
Application granted granted Critical
Publication of ATE482707T1 publication Critical patent/ATE482707T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AT05729786T 2004-03-25 2005-03-23 1-ä2h-1-benzopyran-2-on-8-ylü- piperazin- derivate zur behandlung von schmerzen ATE482707T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55596604P 2004-03-25 2004-03-25
EP04101230 2004-03-25
PCT/EP2005/051328 WO2005092340A1 (en) 2004-03-25 2005-03-23 1-[2h-1-benzopyran-2-one-8-yl]-piperazine derivatives for the treatment of pain

Publications (1)

Publication Number Publication Date
ATE482707T1 true ATE482707T1 (de) 2010-10-15

Family

ID=34928928

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05729786T ATE482707T1 (de) 2004-03-25 2005-03-23 1-ä2h-1-benzopyran-2-on-8-ylü- piperazin- derivate zur behandlung von schmerzen

Country Status (10)

Country Link
US (1) US20050215567A1 (de)
EP (1) EP1732558B1 (de)
JP (1) JP2007530509A (de)
AR (1) AR048112A1 (de)
AT (1) ATE482707T1 (de)
CA (1) CA2554074A1 (de)
PL (1) PL1732558T3 (de)
PT (1) PT1732558E (de)
TW (1) TWI350753B (de)
WO (1) WO2005092340A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1933870B (zh) * 2004-03-23 2010-06-23 皇家飞利浦电子股份有限公司 自存储医用电极
AR049478A1 (es) * 2004-03-25 2006-08-09 Solvay Pharm Bv Un procedimiento para la preparacion de 3-amino-8-(1-piperazinil)-2h-1-benzopiran-2-ona. sales e hidratos y composiciones farmaceuticas.
US20060013874A1 (en) * 2004-07-15 2006-01-19 Solvay Pharmaceuticals B.V. Extended release formulation of 3-amino-8-(1-piperazinyl)-2H-1-benzopyran-2-one
MX2011013324A (es) * 2009-06-10 2012-04-30 Abbott Gmbh & Co Kg Uso de derivados de oxindol sustituidos para el tratamiento y profilaxis del dolor.
EP3523271B1 (de) * 2016-10-10 2020-12-09 Basf Se Katalysatormodifikation mit alkalimetall-, erdalkalimetall- oder seltenerdmetallionen in der kontinuierlichen flüssigphasen-hydrierung von nitroverbindungen

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3586794T2 (de) * 1984-12-21 1993-05-27 Duphar Int Res Arzneimittel mit psychotroper wirkung.
NZ231631A (en) * 1988-12-08 1992-07-28 Duphar Int Res Heterocyclically-substituted piperazine and diazepine derivatives and anxiolytic compositions
US5009895A (en) * 1990-02-02 1991-04-23 Merck & Co., Inc. Sustained release with high and low viscosity HPMC
FR2667068B1 (fr) * 1990-09-26 1994-09-09 Adir Nouvelles amines alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2670491B1 (fr) * 1990-12-14 1993-02-05 Adir Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les renfermant.
EP0650964A1 (de) * 1993-11-02 1995-05-03 Duphar International Research B.V 1- 2H-1-Benzopyran-2-on-8-yl -Piperazin Derivate
US5478572A (en) * 1994-09-06 1995-12-26 Bristol-Myers Squibb Co. Gepirone dosage form
NL9401572A (nl) * 1994-09-27 1996-05-01 Avebe Coop Verkoop Prod Zetmeelprodukten als tabletteerhulpstof, werkwijze voor het bereiden daarvan alsmede werkwijze voor het maken van tabletten.
NZ331860A (en) * 1996-03-29 2000-04-28 Duphar Int Res Piperazine and piperidine compounds with affinity for both dopamine D2 and seratonin 5-HT1A receptors
EP1028958A4 (de) * 1997-10-22 2001-07-18 Lilly Co Eli Arylpiperazine als inhibitoren der serotoninwiederaufnahme und 5-ht1d alpha antagonisten
DE19803131A1 (de) 1998-01-28 1999-07-29 Dolmar Gmbh Kettenmediumpumpe für eine Motorkettensäge sowie Motorkettensäge mit einer solchen Kettenmediumpumpe
PA8469101A1 (es) * 1998-04-09 2000-09-29 Pfizer Prod Inc Ligandos azabiciclicos de receptores 5ht1
US6376494B1 (en) * 1998-06-15 2002-04-23 American Home Products Corporation Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents
US6312717B1 (en) * 1998-07-07 2001-11-06 Bristol-Myers Squibb Company Method for treatment of anxiety and depression
UA62015C2 (en) * 1998-12-28 2003-12-15 Pfizer Prod Inc Benzoizoxazol derivatives, a pharmaceutical composition (variants) based thereon (variants) and a method for treatment (variants)
GB0008563D0 (en) * 2000-04-07 2000-05-24 Cambridge Discovery Chemistry Investigating different physical and/or chemical forms of materials
US20030008880A1 (en) * 2001-05-02 2003-01-09 Pfizer Inc. 4-(2-Pyridyl) piperizines having 5HT7 receptor agonist activity
US6696496B2 (en) * 2002-03-28 2004-02-24 Synthon Bv Low water-soluble venlafaxine salts
US20050215551A1 (en) * 2004-03-25 2005-09-29 Solvay Pharmaceuticals B.V. 1-[2H-1-benzopyran-2-one-8-yl]- piperazine derivatives for the treatment of movement disorders
AR049478A1 (es) * 2004-03-25 2006-08-09 Solvay Pharm Bv Un procedimiento para la preparacion de 3-amino-8-(1-piperazinil)-2h-1-benzopiran-2-ona. sales e hidratos y composiciones farmaceuticas.

Also Published As

Publication number Publication date
TW200534847A (en) 2005-11-01
JP2007530509A (ja) 2007-11-01
TWI350753B (en) 2011-10-21
PL1732558T3 (pl) 2011-03-31
WO2005092340A1 (en) 2005-10-06
AR048112A1 (es) 2006-03-29
PT1732558E (pt) 2010-12-23
EP1732558A1 (de) 2006-12-20
EP1732558B1 (de) 2010-09-29
US20050215567A1 (en) 2005-09-29
CA2554074A1 (en) 2005-10-06

Similar Documents

Publication Publication Date Title
DE602005026984D1 (de) Chinolin-derivate zur behandlung von latenter tuberkulose
DE602005007717D1 (de) Imidazolverbindungen zur behandlung von neurodegenerativen erkrankungen
DE602005023172D1 (de) Hydantoinderivate zur behandlung von entzündlichen erkrankungen
ATE369333T1 (de) Sulfonamidderivate zur behandlung von krankheiten
ATE527241T1 (de) Pyridiazinonderivate zur behandlung von tumoren
ATE375977T1 (de) Sulfonamidderivate zur behandlung von krankheiten
ATE512663T1 (de) Kombination zur behandlung von erkrankungen mit zellproliferation
DE502005010499D1 (de) Implantat zur Behandlung von Fettsucht
DE602005005810D1 (de) Verwendung von substituierten chinolin-derivaten zur behandlung von arzneimittelresistenten mycobakteriellen erkrankungen
DE602005017503D1 (de) Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen
DE60322451D1 (de) 4-Tetrazolyl-4-Phenylpiperidinderivate zur Schmerzbehandlung
ATE534633T1 (de) Indazolderivate zur behandlung von hsp90- induzierten krankheiten
DE502004010131D1 (de) Pyridopyrimidinone zur behandlung von krebserkrankungen
DE602005016141D1 (de) S-mirtazapin zur behandlung von hitzewallungen
DE602006003094D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit
ATE504297T1 (de) Visnadin zur behandlung von kopfhautjucken
ATE526970T1 (de) Behandlung von mastitis
DE602004022035D1 (de) Verwendung von pthalide derivativen zur behandlung
DE602005027251D1 (de) Sulfamide alsendothelinrezeptorantagonsiten zur behandlung von herzkreislauferkrankungen
ATE423099T1 (de) Zur behandlung von schmerzen geeignete piperazine
ATE482707T1 (de) 1-ä2h-1-benzopyran-2-on-8-ylü- piperazin- derivate zur behandlung von schmerzen
DE602005015434D1 (de) Mittel zur behandlung von psychoneurotischen krankheiten
DE60331359D1 (de) Kynurenine 3-hydroxylase inhibitoren zur behandlung von diabetes
ATE448228T1 (de) Pyrrolopyrimidinderivate zur behandlung proliferativer krankheiten
ATE446757T1 (de) 1-ä2h-1-benzopyran-2-one-8-ylü- piperazinderivative zur behandlung von bewegungsstörungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1732558

Country of ref document: EP